DE69935247D1 - Arzneimittel-ziele in candida albicans - Google Patents

Arzneimittel-ziele in candida albicans

Info

Publication number
DE69935247D1
DE69935247D1 DE69935247T DE69935247T DE69935247D1 DE 69935247 D1 DE69935247 D1 DE 69935247D1 DE 69935247 T DE69935247 T DE 69935247T DE 69935247 T DE69935247 T DE 69935247T DE 69935247 D1 DE69935247 D1 DE 69935247D1
Authority
DE
Germany
Prior art keywords
candida albicans
growth
genes
critical
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69935247T
Other languages
English (en)
Other versions
DE69935247T2 (de
Inventor
Roland H Contreras
Bart Nelissen
Backer Marianne Denise De
Walter Herman LUYTEN
Jasmine Elza Viaene
Marc George Logghe
Jorge Eduards Vialard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE69935247D1 publication Critical patent/DE69935247D1/de
Application granted granted Critical
Publication of DE69935247T2 publication Critical patent/DE69935247T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69935247T 1998-12-04 1999-12-06 Arzneimittel-ziele in candida albicans Expired - Fee Related DE69935247T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98204122 1998-12-04
EP98204122 1998-12-04
PCT/EP1999/009833 WO2000034481A2 (en) 1998-12-04 1999-12-06 DRUG TARGETS IN $i(CANDIDA ALBICANS)

Publications (2)

Publication Number Publication Date
DE69935247D1 true DE69935247D1 (de) 2007-04-05
DE69935247T2 DE69935247T2 (de) 2007-10-31

Family

ID=8234434

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935247T Expired - Fee Related DE69935247T2 (de) 1998-12-04 1999-12-06 Arzneimittel-ziele in candida albicans

Country Status (12)

Country Link
US (2) US7125970B1 (de)
EP (1) EP1135503B1 (de)
JP (1) JP2004500016A (de)
AT (1) ATE354658T1 (de)
AU (1) AU773378B2 (de)
CA (1) CA2353525A1 (de)
DE (1) DE69935247T2 (de)
DK (1) DK1135503T3 (de)
ES (1) ES2283147T3 (de)
IL (1) IL143494A0 (de)
NZ (1) NZ511410A (de)
WO (1) WO2000034481A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
CN104342375A (zh) * 2013-07-31 2015-02-11 中国科学院上海生命科学研究院 一种白念珠菌smt3基因的用途及缺失smt3基因的白念珠菌减毒株

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100908A0 (en) * 1991-02-22 1992-11-15 Salk Inst Biotech Ind Invertase genes and their use
IT1282287B1 (it) * 1995-05-16 1998-03-16 Ist Superiore Sanita La sequenza del dna completo dell'inserto carlubo codificante per una proteina heat shch di forda (cansp 70) di candida albicans ceppo atcc
WO1997036925A1 (en) * 1996-04-01 1997-10-09 Scriptgen Pharmaceuticals, Inc. Candida albicans tata-binding protein, nucleic acid and assays
US5863762A (en) * 1996-04-01 1999-01-26 Scriptgen Pharm Inc Nucleic acids encoding TFIIB transcription factor from candida albicans
US5827692A (en) * 1997-04-24 1998-10-27 Heska Corporation Dirofilaria and Brugia ankyrin proteins, nucleic acid molecules, and uses thereof
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
EP1531827A4 (de) * 2002-05-24 2009-07-08 Univ Michigan Kupfer-verringernde behandlung für entzündliche und fibrotische erkrankungen
US20050042646A1 (en) * 2002-08-05 2005-02-24 Davidson Beverly L. RNA interference suppresion of neurodegenerative diseases and methods of use thereof

Also Published As

Publication number Publication date
ES2283147T3 (es) 2007-10-16
NZ511410A (en) 2004-06-25
IL143494A0 (en) 2002-04-21
WO2000034481A3 (en) 2000-11-30
AU773378B2 (en) 2004-05-20
US20070010448A1 (en) 2007-01-11
WO2000034481A2 (en) 2000-06-15
DE69935247T2 (de) 2007-10-31
ATE354658T1 (de) 2007-03-15
JP2004500016A (ja) 2004-01-08
EP1135503A2 (de) 2001-09-26
AU2282700A (en) 2000-06-26
EP1135503B1 (de) 2007-02-21
US7125970B1 (en) 2006-10-24
CA2353525A1 (en) 2000-06-15
DK1135503T3 (da) 2007-06-18

Similar Documents

Publication Publication Date Title
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
ATE237312T1 (de) In liposomen verkapselte nukleinsäurekomplexe
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DE69840387D1 (de) Nik proteine, nukleinsäure sowie verfahren
HUP0400231A2 (hu) Rákos megbetegedések kezelésében különösen hasznos, immundecepcióra szolgáló eljárások és gyógyszerkészítmények
HUP9901072A2 (hu) Szintetikus emlőskromoszóma és eljárások előállítására
NO20055209L (no) Peptabody for cancerbehandling
BR9911349A (pt) Genes para a biossìntese de epotilonas
ATE293169T1 (de) Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
DE69935247D1 (de) Arzneimittel-ziele in candida albicans
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
DK1693451T3 (da) Fremgangsmåde til dyrkning af myokardieceller
BR9806183A (pt) Quinases de proteìna e usos das mesmas
PT1140023E (pt) Formulacoes cocleares integrativas de proteina-adn e metodos de transformacao celular
WO2003092736A3 (en) Peptide nucleic acid conjugates with transporter peptides
ITMI20030860A1 (it) Metodo per l'inibizione selettiva del gene n-myc
WO2003059262A3 (en) Method and composition for treating and preventing hiv infection and aids
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
WO1998024887A3 (en) Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: CONTRERAS, ROLAND H., B-9000 GENT, BE

Inventor name: NELISSEN, BART, B-2340 BEERSE, BE

Inventor name: DE BACKER, MARIANNE, DENISE, B-2340 BEERSE, BE

Inventor name: LUYTEN, WALTER, HERMAN, MARIA, LOUIS, B-2340 B, BE

Inventor name: VIAENE, JASMINE, ELZA, B-9000 GENT, BE

Inventor name: LOGGHE, MARC, GEORGE, B-9000 GENT, BE

Inventor name: VIALARD, JORGE, EDUARDS, B-2340 BEERSE, BE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee